KIDNEY PATHOLOGY IN JUVENILE RHEUMATOID ARTHRITIS IN CHILDREN
https://doi.org/10.24884/1561-6274-2013-17-3-33-45
Abstract
Literature review summarize features of amyloid nephropathy in children and adult patients with rheumatoid arthritis, discuss the diagnostic value of the serum amyloid precursor protein (SAA) levels in blood.
About the Author
A. A. Stepanova
ГБОУ ВПО Санкт-Петербургский государственный педиатрический медицинский университет Минздрава России
Russian Federation
Russian Federation
References
1. Каневская МЗ, Варшавский ВА. К проблеме ревматоидной нефропатии. Тер арх 2003; 75(5): 24-29
2. Koivuniemi R, Paimela L, Leirisalo-Repo M. Causes of death in patients with rheumatoid arthritis from 1971 to 1991 with special reference to autopsy. Clin Rheumatol 2009; 28: 1443–1447
3. Pathan E, Joshi VR. Rheumatoid Arthritis and The Kidney. JAPI 2004; 52: 488-494
4. Алексеева ЕИ, Шахбазян ИВ. Ювенильный ревматоидный артрит. В: Самсыгина ГА, Щербакова МЮ, ред. Кардиология и ревматология детского возраста. ИД Медпрактика-М, М., 2004; 744
5. Алексеева ЕИ, Литвицкий ПФ. Ювенильный ревматоидный артрит: этиология, патогенез, клиника, алгоритмы диагностики и лечения. ВЕДИ, М., 2007; 308
6. Youn-Soo Hahn, Joong-Gon Kim. Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis. Korean J Pediatr 2010; 53(11): 921-930
7. Новик ГА, Абакумова ЛН, Летенкова НМ и др. Ювенильные артриты – опыт диагностики и лечения. Лечащий врач 2008; 4: 23-27
8. Насонов ЕЛ, ред. Ревматология: Клинические рекомендации. ГЭОТАР-Медиа, М., 2011; 752
9. Воронцов ИМ, Дубко МФ, Летенкова НМ и др. Ювенильные артриты. Опыт диагностики, клинического группирования и терапии. Вестник Педиатрической академии 2004: 13-19
10. Папаян АВ, Савенкова НД, ред. Клиническая нефрология детского возраста. Левша. Санкт-Петербург, СПб., 2008; 600
11. Wallace CA. Current management of juvenile idiopathic arthritis. Practice & Research Clinical Rheumatology 2006; 20(2): 279–300
12. Насонова ВА., Астапенко МГ. Клиническая ревматология: руководство. Медицина, М., 1989; 590
13. Arvidsson NG, Gudbjörnsson B, Hällgren R, Larsson A. Concordant message of different inflammatory markers in patients with rheumatoid arthritis. Ups J Med Sci 1998; 103(1): 35-42
14. Саркисова ИА. Ревматоидный артрит как ведущая причина развития вторичного АА-амилоидоза (Обзор литературы). Нефрология и диализ 2006; 8(1): 15-26
15. Sokka T, Envalds M, Pincus T. Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod Rheumatol 2008; 18: 228–239
16. Kwang NK. Treatment of juvenile rheumatoid arthritis. Korean J Pediatr 2010; 53(11): 936-941
17. Ito S, Tsutsumi A, Harada T et al. Long-term remission of nephrotic syndrome with etanercept for concomitant juvenile idiopathic arthritis. Pediatr Nephrol 2010; 25: 2175–2177
18. Ruperto N, Lovell DJ, Cuttica R et al. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: fi ndings from an open-label treatment extension. Ann Rheum Dis 2010; 69: 718–722
19. Boers M, Croonen AM, Dijkmans BAC et al. Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies. Ann Rheum Dis 1987; 46: 658–663
20. Al-Ghamdi A, Attar S. Extra-articular manifestations of rheumatoid arthritis: a hospital-based study. Ann Saudi Med 2009; 29(3): 189-193
21. Helin HJ, Korpela MM, Mustonen JT, Pasternack AI. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 1995; 38(2): 242-247
22. Nakano M, Ueno M, Nishi S et al. Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis. Clinical nephrology 1998; 50(3): 154-160
23. Karstila K, Korpela M, Sihvonen S, Mustonen J. Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study. Clin Rheumatol 2007; 26(12): 2089-2095
24. Пономарева ЕЮ, Никитина НМ. Поражение почек при ревматоидном артрите. Нефрология 2004; 8, приложение 2: 145-146
25. Harper L, Cockwell P, Howie AJ et al. Focal segmental necrotizing glomerulonephritis in rheumatoid arthritis. Q J Med 1997; 90: 125-132
26. Савенкова НД, Папаян АВ. Нефротический синдром в практике педиатра. Эскулап, СПб, 1999; 256
27. Шишкин АН, Янченко ДЕ, Козлов ВВ. Прогностические критерии и выживаемость у больных с вторичным амилоидозом почек. Нефрология 2000; 4: 15-21
28. Lachmann H, Gilbertson J, Gallimore R. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007; 356: 2361-2371
29. Смирнов АВ, Шилов ЕМ, Добронравов ВA и др. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Национальные рекомендации. Нефрология 2012; 16(1): 89-115
30. Suzuki S, Konta T, Koizumi R et al. Fibrillary glomerulonephritis with hypocomplementemia. Internal medicine 2003; 42(8): 719-722
31. Koseki Y, Terai C, Moriguchi M et al. A prospective study of renal disease in patients with early rheumatoid arthritis. Ann Rheum Dis 2001; 60: 327–331
32. Daoussis D, Panoulas VF, Antonopoulos I et al. Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 2010; 69(3): 517-521
33. Gedalia A, Mendez EA, Craver R et al. Renal involvement in juvenile rheumatoid arthritis: report of two cases. Clin Rheumatol 2001; 20: 153–156
34. Varma S. Juvenile rheumatoid arthritis with focal segmental glomerulosclerosis: a rare association. Pediatr Nephrol 2010; 25: 2189–2190
35. Reed AM, Haugen M, Pachman LM et al. The repair of osteopenia in children with juvenile rheumatoid arthritis. J Pediatr 1993; 122: 693-696
36. Батян ГМ, Кожарская ЛГ, Юшко ВД и др. Особенности иммунного статуса больных ювенильным ревматоидным артритом (ЮРА) с поражением почек. Материалы Всероссийской научно-практической конференции «проблемы детской нефрологии», посвящённой 75-летию НИИ педиатрии РАМН (Москва 15-16 октября 1997). М., 1997: 25
37. Pedersen LM, Nordin H, Svensson B, Bliddal H. Microalbuminuria in patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 189-192
38. Витворт ДжА, Лоренс Дж Р, ред. Руководство по нефрологии. Перевод с англ. Под ред. Ю.В. Наточина. Медицина, М., 2000; 486
39. Sharma R, Jain S, Kher V. ANCA-associated Goodpasture’s syndrome in a patient with rheumatoid arthritis on penicillamine. Indian J Nephrol 2012; 22(1): 45–47
40. Stokes MB, Foster K, Markowitz GS et al. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 2005; 20(7): 1400-1406
41. Yilmaz M, Unsal A, Sokmen M et al. Duodenal biopsy for diagnosis of renal involvement in amyloidosis. Clin Nephrol 2012; 77(2): 114-118
42. Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 1991; 70(4): 246-256
43. Рамеев ВВ, Козловская ЛВ, Саркисова ИА. Амилоидоз: вопросы диагностики и лечения. Клиницист 2006; 4: 35-41
44. Immonen K, Pettersson T, Finne P et al. Decline in the incidence of renal failure due to amyloidosis associated with inflammatory rheumatic diseases. Amyloid 2010; 17 (Suppl 1): 149
45. Koivuniemi R, Paimela L, Suomalainen R et al. Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid 2008; 15(4): 262-268
46. Малкоч АВ, Хасабов НН. Амилоидоз. В: Таболин ВА, Бельмер СВ, Османов ИМ, ред. Нефрология детского возраста. ИД МЕДПРАКТИКА-М, М., 2005; 519-538
47. Шишкин АН. Амилоидные болезни. Медицина XXI век 2008; 9(10): 44-51
48. Bergesio F, Ciciani AM, Santostefano M et al. Renal involvement in systemic amyloidosis – an Italian retrospective study on epidemiological and clinical data at diagnosis. Nephrol Dial Transplant 2007; 22: 1608–1618
49. Tuglular S, Yalcinkaya F, Paydas S et al. A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 2002; 17: 2003-2005
50. Кочубей ЛН, Виноградова ОМ, Серов ВВ, Васильева НА. Прогноз и выживаемость больных вторичным амилоидозом (анализ 146 случаев). Тер. арх 1993; 6: 48-54
51. Potysova Z, Merta M, Tesar V et al. Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre. Int Urol Nephrol 2009; 41: 941–945
52. Chevrel G, Jenvrin C, McGregor B, Miossec P. Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology 2001; 40: 821–825
53. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. The New England Journal of Medicine 1997; 25: 898-909
54. Рамеев ВВ, Козловская ЛВ, Малинина ЕА и др. Определение циркулирующих белков-предшественников амилоида в диагностике и мониторировании течения системного амилоидоза. Клиническая нефрология 2009; 55-62
55. Wilkins J, Gallimore JR, Tennent GA et al. Rapid Automated Enzyme Immunoassay of Serum Amyloid A. Clin. Chem. 1994; 40(7): 1284-1290
56. Lannergård A, Friman G, Ewald U et al. Serum amyloid A (SAA) protein and high-sensitivity C-reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults. Acta Paediatr 2005; 94(9): 1198-1202
57. Obici L, Raimondi S, Lavatelli F et al. Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview. Arthritis & Rheumatism 2009; 61(10): 1435–1440
58. Cunnane G, Grehan S, Geoghegan S et al. Serum amyloid A in the assessment of early inflammatory arthritis. Journal of Rheumatology 2000; 27: 58–63
59. Li TW, Zheng BR, Huang ZX et al. Screening diseaseassociated proteins from sera of patients with rheumatoid arthritis: a comparative proteomic study. Chinese Medical Journal 2010; 123(5): 537-543
60. Targoñska-Stêpniak B, Dryglewska M, Majdan M. Influence of long-term leflunomide treatment on serum amyloid concentration in rheumatoid arthritis patients. Pharmocological reports 2010; 62: 719-725
61. Verine J, Mourad N, Desseaux K et al. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response. Hum Pathol 2007; 38(12): 1798-1809
62. Nakamura T. Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatment. Clin Exp Rheumatol 2011; 850–856
63. Yamada T, Sato J, Okuda Y. Affinity of SAA with HDL may partially interpret SAA1 polymorphism related AA amyloidogenesis. Amyloid 2010; 17 (Suppl 1): 94
64. Magy N, Benson MD, Liepnieks JJ et al. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model. Amyloid 2007; 14(1): 51-63
65. Connolly M, Veale DJ, Fearon U. Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis. Ann Rheum Dis 2011; 70(7): 1296-1303
66. Cai H, Song C, Endoh I et al. Serum amyloid A induces monocyte tissue factor. J Immunol 2007; 178: 1852-1860
67. Okamoto H, Katagiri Y, Kiire A et al. Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products. J Rheumatol 2008; 35(5): 752-756
68. Степанова АА, Савенкова НД, Новик ГА и др. Концентрация сывороточного белка-предшественника амилоида в крови у больных ювенильным ревматоидным артритом, имеющих протеинурию. Нефрология 2012; 16(3), выпуск 2: 48-53
69. Okuda Y, Takasugi K, Oyama T et al. Amyloidosis in rheumatoid arthritis: clinical study of 124 histologically proven cases. Ryumachi 1994; 34: 939-946
70. Kuroda T, Tanabe N, Kobayashi D et al. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in reactive amyloidosis associated with rheumatoid arthritis. Rheumatol Int 2012; 32(10): 3155-3162
71. Hamberg H, Westermark GT, Davey E, Westermark P. Renal papillary necrosis in systemic amyloidoses. Amyloid 2010; 17 (Suppl 1): 183
72. Benucci M, Maniscalchi F, Manfredi M. Secondary amyloidosis complicated rheumatoid arthritis, prevalence study in Italian population. Recenti Prog Med 2007; 98(1): 16-19
73. Anelli MG, Torres DD, Manno C et al. Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab. Arthritis & Rheumatism 2005; 52(8): 2519–2520
74. Perry ME, Stirling A, Hunter JA. Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis. Clin Rheumatol 2008; 27(7): 923-925
75. Kuroda T, Wada Y, Kobayashi D et al. Effective anti-TNFalpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis. J Rheumatol 2009; 36(11): 2409-2415
76. Kuroda T, Tanabe N, Kobayashi D et al. Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis. J Rheumatol 2012; 39(7): 1348-1354
77. Blank N, Lorenz HM. Diagnostics and therapy of AA amyloidosis. Pathologe 2009; 30(3): 219-225
78. Murata S, Ueda M, Tanabe Y et al. Inhibitory effects of anti-IL-1 beta antibody in murine AA amyloidosis model. Amyloid 2010; 17 (Suppl 1): 114
79. Kluve-Beckerman B, Benson MD. AA amyloidosis: potential therapy with antisense oligonucleotides. Amyloid 2010; 17 (Suppl 1): 117
80. Wien TN, Leivestad T, Reisæter AV et al. Kidney transplantation in AA amyloidosis. Amyloid 2010; 17 (Suppl 1): 117
81. Gillmore JD, Lovat L.B, Persey MR et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001; 358(9275): 4-5
82. Kuroda T, Tanabe N, Harada T et al. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol 2006; 25: 498–505
83. Ueno T, Takeda K, Nagata M. Remission of proteinuria and preservation of renal function in patients with renal AA amyloidosis secondary to rheumatoid arthritis. Nephrol Dial Transplant 2012; 27(2): 633-639
Review
For citations:
Stepanova A.A. KIDNEY PATHOLOGY IN JUVENILE RHEUMATOID ARTHRITIS IN CHILDREN. Nephrology (Saint-Petersburg). 2013;17(3):33-45. (In Russ.) https://doi.org/10.24884/1561-6274-2013-17-3-33-45
Views:
636
Email this article 